Ep 52: knownwell CMO Dr. Angela Fitch on The Future of GLP-1s and New Approaches to Obesity Medicine
Vital Signs with Jacob Effron and Nikhil Krishnan
Exploring the Broad Benefits of GLP-1 Medications
This chapter explores the evolving applications of GLP-1 medications, highlighting their potential in treating not just obesity but also conditions like Alzheimer's and cardiovascular issues. The discussion examines the possibility of these drugs playing a significant role in long-term disease modification and their broader implications for patient care.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
